Académique Documents
Professionnel Documents
Culture Documents
Michelle D Kelly
10/17/09 1
Agenda
Overview
Who
What
Where
How
Summary
10/17/09 2
Who?
Sub Saharan Africans
Adults
Children and infants
Health workers
10/17/09 3
What
Arbovirus
Chikungunya
Aedes mosquitos
Human to Human
New strains
10/17/09 4
Where
10/17/09 5
10/17/09 6
How
Global warming
Travel
Exported goods
Evolving Genome
10/17/09 7
Summarize
What is known
Vaccines not in pipeline
Lab testing - PCR not credible
Populations at risk
Evidence of higher AR & CFR
Maternal-child transmission
Health workers at risk
10/17/09 8
Guidelines
World Health Organization
Clinical Management of Chikungunya
10/17/09 9
Gap in Guidelines
10/17/09 10
Recommendation
Prevent Chikungunya at
the Village level
10/17/09 11
INTERVENTIONS AND PRACTICES
CONSIDERED
1. Risk Assessment
2. Primary Prevention
3. Secondary Prevention
10/17/09 12
MAJOR OUTCOMES CONSIDERED
u Prevent Morbidity
10/17/09 13
Risk Assessment
assessment
environment
vector
occupations and activities
that expose persons
migration/ market
movement patterns
10/17/09 14
Primary Prevention
10/17/09 15
Secondary Prevention
Screen
10/17/09 16
Next Steps
10/17/09 17
Evaluation and Monitoring
Examples of prevention metrics:
Number of:
communities informed of chikungunya risk
10/17/09 18
Prevent Morbidity